Chronic fructose renders pancreatic β-cells hyper-responsive to glucose-stimulated insulin secretion through extracellular ATP signaling

Am J Physiol Endocrinol Metab. 2019 Jul 1;317(1):E25-E41. doi: 10.1152/ajpendo.00456.2018. Epub 2019 Mar 26.

Abstract

Fructose is widely used as a sweetener in processed food and is also associated with metabolic disorders, such as obesity. However, the underlying cellular mechanisms remain unclear, in particular, regarding the pancreatic β-cell. Here, we investigated the effects of chronic exposure to fructose on the function of insulinoma cells and isolated mouse and human pancreatic islets. Although fructose per se did not acutely stimulate insulin exocytosis, our data show that chronic fructose rendered rodent and human β-cells hyper-responsive to intermediate physiological glucose concentrations. Fructose exposure reduced intracellular ATP levels without affecting mitochondrial function, induced AMP-activated protein kinase activation, and favored ATP release from the β-cells upon acute glucose stimulation. The resulting increase in extracellular ATP, mediated by pannexin1 (Panx1) channels, activated the calcium-mobilizer P2Y purinergic receptors. Immunodetection revealed the presence of both Panx1 channels and P2Y1 receptors in β-cells. Addition of an ectonucleotidase inhibitor or P2Y1 agonists to naïve β-cells potentiated insulin secretion stimulated by intermediate glucose, mimicking the fructose treatment. Conversely, the P2Y1 antagonist and Panx1 inhibitor reversed the effects of fructose, as confirmed using Panx1-null islets and by the clearance of extracellular ATP by apyrase. These results reveal an important function of ATP signaling in pancreatic β-cells mediating fructose-induced hyper-responsiveness.

Keywords: AMPK; ATP; fructose; insulin secretion; pancreatic islet; pannexin; purinergic receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / genetics
  • AMP-Activated Protein Kinases / metabolism
  • Adenosine Triphosphate / metabolism
  • Adenosine Triphosphate / physiology*
  • Animals
  • Apyrase / metabolism
  • Connexins / genetics
  • Connexins / metabolism
  • Fructose / pharmacology*
  • Glucose / pharmacology*
  • Humans
  • Insulin Secretion / drug effects*
  • Insulin-Secreting Cells / drug effects*
  • Insulin-Secreting Cells / metabolism*
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Purinergic P2Y Receptor Agonists / pharmacology
  • Purinergic P2Y Receptor Antagonists / pharmacology
  • Receptors, Purinergic P2Y / drug effects
  • Receptors, Purinergic P2Y / metabolism
  • Receptors, Purinergic P2Y1 / drug effects
  • Receptors, Purinergic P2Y1 / metabolism
  • Signal Transduction / drug effects*

Substances

  • Connexins
  • Nerve Tissue Proteins
  • Panx1 protein, mouse
  • Purinergic P2Y Receptor Agonists
  • Purinergic P2Y Receptor Antagonists
  • Receptors, Purinergic P2Y
  • Receptors, Purinergic P2Y1
  • Fructose
  • Adenosine Triphosphate
  • AMP-Activated Protein Kinases
  • Apyrase
  • Glucose